Finance

Lists
Why is 6185 down 4.77%?
Dive Deeper
6185:HKG
Cansino Biologics Inc
HK$31.52
-4.77%
(-1.58) 1D
Oct 13, 10:02:20 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6185...
Open
HK$32.00
High
HK$33.12
Low
HK$31.56
Mkt. cap
16.07B
Avg. vol.
6.16M
Volume
1.74M
P/E ratio
163.85
52-wk high
HK$47.80
52-wk low
HK$19.22
EPS
HK$0.19
No. of employees
1K
Open
HK$32.00
High
HK$33.12
Low
HK$31.56
Mkt. cap
16.07B
Avg. vol.
6.16M
Volume
1.74M
P/E ratio
163.85
52-wk high
HK$47.80
52-wk low
HK$19.22
EPS
HK$0.19
No. of employees
1K
News stories
From web sources and news partners
Profile
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
About Cansino Biologics Inc
CEOXuefeng Yu
Employees1.18K
FoundedJan 13, 2009
Headquarters-
SectorBiotechnology
Websitecansinotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
310.24M
375.34M
190.28M
359.54M
Cost of goods sold
55.37M
129.82M
36.26M
97.60M
Cost of revenue
55.37M
129.82M
36.26M
97.60M
Research and development expenses
76.87M
88.37M
71.41M
84.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158.60M
187.81M
116.85M
158.72M
Operating expense
218.49M
325.84M
182.92M
258.68M
Total operating expenses
273.86M
455.66M
219.19M
356.28M
Operating income
36.38M
-80.32M
-28.90M
3.26M
Other non operating income
-8.06M
5.34M
-9.91M
7.97M
EBT including unusual items
27.79M
13.25M
-34.38M
40.42M
EBT excluding unusual items
40.15M
-74.47M
-36.57M
-3.72M
Income tax expense
-134.75K
-181.72K
6.04M
714.36K
Effective tax rate
-0.48%
-1.37%
-17.58%
1.77%
Other operating expenses
-15.79M
50.87M
-9.21M
12.43M
Net income
27.93M
13.43M
-40.42M
39.70M
Net profit margin
9.00%
3.58%
-21.24%
11.04%
Earnings per share
-
-
-
-
Interest and investment income
13.97M
21.09M
9.43M
12.84M
Interest expense
-11.11M
-3.20M
-7.19M
-5.91M
Net interest expenses
2.86M
17.88M
2.24M
6.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
82.74M
-39.25M
12.18M
49.79M
Gain or loss from assets sale
84.72K
-137.05K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps